These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 28012891)

  • 21. Potential for Treatment of Neurodegenerative Diseases with Natural Products or Synthetic Compounds that Stabilize Microtubules.
    Miller JH; Das V
    Curr Pharm Des; 2020; 26(35):4362-4372. PubMed ID: 32564745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microtubule dynamics and the neurodegenerative triad of Alzheimer's disease: The hidden connection.
    Brandt R; Bakota L
    J Neurochem; 2017 Nov; 143(4):409-417. PubMed ID: 28267200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of axonal transport in neurodegeneration.
    Berth SH; Lloyd TE
    J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37259916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tubulin polyglutamylation, a regulator of microtubule functions, can cause neurodegeneration.
    Bodakuntla S; Janke C; Magiera MM
    Neurosci Lett; 2021 Feb; 746():135656. PubMed ID: 33482309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.
    Karnati HK; Panigrahi MK; Gutti RK; Greig NH; Tamargo IA
    J Alzheimers Dis; 2015; 48(3):563-80. PubMed ID: 26402105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders.
    Eira J; Silva CS; Sousa MM; Liz MA
    Prog Neurobiol; 2016 Jun; 141():61-82. PubMed ID: 27095262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biophysical challenges to axonal transport: motor-cargo deficiencies and neurodegeneration.
    Encalada SE; Goldstein LS
    Annu Rev Biophys; 2014; 43():141-69. PubMed ID: 24702007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophagosome dynamics in neurodegeneration at a glance.
    Wong YC; Holzbaur EL
    J Cell Sci; 2015 Apr; 128(7):1259-67. PubMed ID: 25829512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport.
    Jouroukhin Y; Ostritsky R; Assaf Y; Pelled G; Giladi E; Gozes I
    Neurobiol Dis; 2013 Aug; 56():79-94. PubMed ID: 23631872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases.
    Brady ST; Morfini GA
    Neurobiol Dis; 2017 Sep; 105():273-282. PubMed ID: 28411118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurodegeneration and microtubule dynamics: death by a thousand cuts.
    Dubey J; Ratnakaran N; Koushika SP
    Front Cell Neurosci; 2015; 9():343. PubMed ID: 26441521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrograde axonal transport: pathways to cell death?
    Perlson E; Maday S; Fu MM; Moughamian AJ; Holzbaur EL
    Trends Neurosci; 2010 Jul; 33(7):335-44. PubMed ID: 20434225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microtubule Dysfunction: A Common Feature of Neurodegenerative Diseases.
    Sferra A; Nicita F; Bertini E
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tau proteins harboring neurodegeneration-linked mutations impair kinesin translocation in vitro.
    Yu D; LaPointe NE; Guzman E; Pessino V; Wilson L; Feinstein SC; Valentine MT
    J Alzheimers Dis; 2014; 39(2):301-14. PubMed ID: 24150109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of axonal transport in neurodegenerative diseases.
    De Vos KJ; Grierson AJ; Ackerley S; Miller CC
    Annu Rev Neurosci; 2008; 31():151-73. PubMed ID: 18558852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microtubule acetylation: A reading key to neural physiology and degeneration.
    Cappelletti G; Calogero AM; Rolando C
    Neurosci Lett; 2021 Jun; 755():135900. PubMed ID: 33878428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tools for the rational design of bivalent microtubule-targeting drugs.
    Marangon J; Christodoulou MS; Casagrande FV; Tiana G; Dalla Via L; Aliverti A; Passarella D; Cappelletti G; Ricagno S
    Biochem Biophys Res Commun; 2016 Oct; 479(1):48-53. PubMed ID: 27613098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The binding sites of microtubule-stabilizing agents.
    Field JJ; Díaz JF; Miller JH
    Chem Biol; 2013 Mar; 20(3):301-15. PubMed ID: 23521789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Going new places using an old MAP: tau, microtubules and human neurodegenerative disease.
    Garcia ML; Cleveland DW
    Curr Opin Cell Biol; 2001 Feb; 13(1):41-8. PubMed ID: 11163132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Case for Microtubule Vulnerability in Amyotrophic Lateral Sclerosis: Altered Dynamics During Disease.
    Clark JA; Yeaman EJ; Blizzard CA; Chuckowree JA; Dickson TC
    Front Cell Neurosci; 2016; 10():204. PubMed ID: 27679561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.